InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-38.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the complete record of transactions filed by MacBeath Gavin, Directeur Scientifique. Insider active across 1 company, notably TScan Therapeutics, Inc.. Aggregated, 1 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €26k. Activity tracked since 20 September 2021. The latest transaction was filed on 20 September 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to MacBeath Gavin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
4,943 shares@ US$6.2197100.0% of flowVoting Common StockSEC:0000899243-21-037147:0
Canonical exit: 19 Dec 2021 (T+90)
1 of 1 declaration
About MacBeath Gavin
Gavin MacBeath is the Chief Scientific Officer of TScan Therapeutics, Inc. In this role, he is responsible for leading the company's research and development initiatives. With a strong scientific background, he plays a key role in innovation and the development of new therapies. His expertise is essential in ensuring that TScan's products meet the highest standards of safety and efficacy.
